You might be here because…

The reason most people search for stem cells or exosomes.

Your knee or shoulder pain isn't getting better

Physical therapy plateaued. Cortisone worked once, then didn't. You want to avoid surgery — or delay it — if there's a real alternative.

You haven't been the same since a concussion or COVID

Brain fog, headaches, cognitive slowing that traditional care hasn't touched. You're looking for a therapy aimed at repair, not just symptom control.

You want to age well

You're building a real longevity plan and want to understand where cell-based therapy fits — without the hype.

An honest note on regulatory status

  • The U.S. Food & Drug Administration (FDA) has not approved any exosome products for the treatment of any disease, and has not approved MSC therapies for orthopedic, neurologic, or anti-aging use.
  • These therapies are considered investigational. Evidence is strongest for joint and musculoskeletal use and is growing for neurologic and longevity applications, but published trials remain limited in size and follow-up.
  • We follow FDA guidance and use only well-characterized products from vetted, U.S.-based labs. See the FDA Consumer Alert on Regenerative Medicine Products.
  • We will never promise a cure. We will explain what the research supports, what it doesn't, and what a realistic outcome looks like for your case — before you decide.

Our philosophy

Signals matter as much as cells.

Modern regenerative science has shifted from “replace the damaged tissue” to “reactivate the body's own repair signals.” Exosomes — tiny extracellular vesicles that shuttle growth factors, microRNA, and repair signals between cells — appear to do much of the healing work once attributed to stem cells themselves. We use both, thoughtfully, and only when the case fits.

Careful patient selection

Not everyone is a candidate. We evaluate the injury, imaging, labs, and goals — and often start with less invasive options first.

Quality-controlled products

Only vetted U.S. laboratories with published characterization, sterility testing, and dosing standards. No overseas or unregulated sources.

Measured expectations

Response varies. We track outcomes with the same functional scales, imaging, and cognitive metrics we use across the practice.

Recovery adjuncts

What happens after the injection matters as much as the injection itself. Structured post-procedure care may include infrared sauna to support heat-shock proteins and mitochondrial function, targeted IV nutrients, ozone when indicated, and a graded return-to-activity plan.

Three focus areas

Where we use stem cell & exosome therapies.

Every plan is a subset of these — chosen for your specific case.

1 · Joint pain & musculoskeletal repair

Our largest and best-studied use case. Chronic knee, hip, shoulder, and back pain that hasn't fully responded to physical therapy, injections, or conservative care. MSC and exosome-based therapies may reduce inflammation and support cartilage and soft-tissue repair.

  • Knee & hip osteoarthritis
  • Shoulder rotator cuff & labral wear
  • Chronic tendon & ligament injuries
  • Post-surgical recovery support
  • Low back & SI joint pain

2 · Brain, cognitive & neurologic support

An emerging area with a growing preclinical and early clinical evidence base. Exosome and stem-cell-derived signals appear to reduce neuroinflammation and support neuronal function. We use these carefully, most often as an adjunct to the Brain Health Program.

  • Post-concussion & TBI recovery
  • Long-COVID cognitive symptoms
  • Age-related cognitive decline (adjunct)
  • Neuroinflammation associated with autoimmunity
  • Peripheral nerve recovery support

3 · Anti-aging & longevity

Regenerative therapies used as part of a broader longevity plan — paired with biological age testing, hormone optimization, and metabolic care. The goal is healthy function, not chasing a specific number.

  • Systemic inflammation reduction
  • Cellular senescence support
  • Skin, hair & connective tissue vitality
  • Integration with TruDiagnostic biological age testing
  • Coordination with hormone optimization

4 · Delivery routes we use

Route matters. We match delivery to the target tissue and the goal.

  • Joint injection — direct delivery for musculoskeletal use
  • Intravenous (IV) — systemic delivery for inflammation, longevity, cognitive adjunct
  • Intranasal — for select neurologic protocols (adjunct)
  • Combined with ozone or IV nutrient support when indicated

Who this is for

Realistic candidates for regenerative therapy.

Best fits

  • Chronic joint pain that has plateaued with PT / injections
  • Post-concussion or long-COVID cognitive symptoms
  • Post-surgical recovery support
  • Longevity patients optimizing an already-stable baseline

Not a fit (right now)

  • Active cancer or recent cancer treatment (case-by-case)
  • Active infection or uncontrolled autoimmune flare
  • Bone-on-bone joints where surgery is the right next step
  • Patients expecting a single "miracle" treatment

What to expect

  • Detailed intake & review of imaging / labs
  • Honest discussion of expected response
  • Structured post-treatment plan (rehab, anti-inflammatory support)
  • Follow-up scoring at 30, 60, 90 days

The evidence library

What the research actually says.

Peer-reviewed studies grouped by topic. We include limitations honestly — regenerative medicine is a maturing field, and the strongest evidence is in joint use.

Stem cell (MSC) therapy for knee osteoarthritis — meta-analyses
Exosomes for joint & soft-tissue repair
Exosomes for brain & cognitive support
MSC & MSC-EVs for longevity / anti-aging
FDA regulatory status & public safety context

Studies are provided so you can read primary sources. They inform our thinking; they don't guarantee any individual result.

Common questions

What people usually want to know.

Are stem cell and exosome treatments FDA-approved?

No. Neither exosomes nor MSC therapies are FDA-approved for orthopedic, neurologic, or anti-aging use. They are considered investigational. We use products from vetted U.S. labs, and we discuss the state of the evidence honestly at your consultation.

Is this covered by insurance?

No. Regenerative therapies are cash-pay wellness services. HSA and FSA accounts are sometimes eligible — check with your plan. See our Billing page for details.

How is this different from PRP?

Platelet-rich plasma (PRP) uses your own blood-derived growth factors. Exosome and MSC therapies use externally-sourced products that carry more concentrated and diverse repair signals. Both have a role. PRP is often the right first step; regenerative products are typically considered when PRP and conservative care have plateaued.

How many sessions will I need?

It depends on the target. Joint protocols are typically 1–3 sessions spaced weeks apart. IV protocols vary. We build a plan tailored to your case, not a package.

What are the risks?

Reported risks in published studies are low but not zero — most commonly transient injection-site pain or inflammation. Because these products are investigational, longer-term risks are not fully characterized. We review individual risk with you at consultation.

Can you combine this with ozone or peptide therapy?

Yes — and we often do. Ozone, IV nutrient support, and select peptides can be paired thoughtfully to amplify recovery signals. See our Weight Loss & Peptides page for the recovery-focused version.

Curious if stem cell or exosome therapy fits your case?

A 20-minute discovery call is the easiest way to learn if we're the right fit for you.

Book a Discovery Call